Archives: 4/2008

diabetesmine logo small 2nd Annual DiabetesMine™ Design ChallengeMedgadget is proud to announce our co-sponsorship of the 2nd Annual DiabetesMine™ Design Challenge – “a competition designed to foster innovation in diabetes design and encourage creative new tools that will improve life with diabetes”. The contest is looking for unique, practical, and novel design ideas that may one day be applied to real products. The winners of the design challenge will receive both prize money and consulting time with design firm IDEO.
Below is from the official announcement:

56765gif 2nd Annual DiabetesMine™ Design Challenge

2nd Annual DiabetesMine™ Design Challenge*
* a competition designed to foster innovation in diabetes design and get the creative juices flowing around new concepts and tools to improve life with diabetes*
Two of the most enticing design concepts will win a package of prizes to help further their creative efforts: $1,000 in cash, some pro-bono professional advice from world-renowned design experts, and free access to the next Health 2.0 conference for one adult winner.
ideo logo 2nd Annual DiabetesMine™ Design ChallengeThis contest is co-hosted by my friends over at Medgadget, the Internet journal of emerging medical technologies, and supported by the world-renowned design firm IDEO, with headquarters in Palo Alto, CA. The campaign is generously sponsored by Cory and Justin Oringer, two young brothers (ages 14 and 11, respectively) who have both been living with Type 1 diabetes for more than 10 years each and have already seen and personally experienced many wonderful benefits of design innovation in diabetes technology. Just a few of the innovations that have changed their lives include:

  • blood glucose tests that previously took 30 seconds now take only 5 seconds
  • 5 microliter droplets of blood required have now shrunk to just .3 microliters
  • where we once there was finger sticking only, we can now use alternate sites (nighttime toe testing gives the boys’ fingers some healing relief)
  • multiple injections have now given way to the option for pumping with convenient temp basals, correction calculators, and "bolus wizards"
  • 21g lancets have slimmed down to just 30g needles, now available in "virtually painless" lancing devices like Renew and Pelikan
  • These devices provide the lancet needles in cartridge form, doing away with accidental needle sticks (Cory’s schoolmate once poked himself with a lost lancet, creating havoc at their school)
  • At the same time, Cory and Justin have witnessed (and lived) the revolution in communication we fondly know as Social Media. Who ever heard of a "blog" back when they were diagnosed? User-generated content has changed lives, and driven a whole new wave of excitement about contests and challenges (think American Idol, Dancing with the Stars, Survivor, and The Apprentice).
    "With a father deeply entrenched in the diabetes business, Cory and Justin inevitably wind up in the midst of numerous innovation-brainstorming conversations. They’re very excited to be involved in the DiabetesMine Design Challenge," the family writes to me.
    Now for the particulars:
    THE BACKGROUND
    It was just about this time last year that I posted my Open Letter to Steve Jobs, calling for the gods of consumer design to help revolutionize design of diabetes devices. This spurred a ton of conversation across the blogosphere and mainstream media. In the weeks and months that followed, all sorts of individuals and organizations came forward with many compelling new prototypes, designs, and ideas.
    This year, we’re making it an official competition, laying down the gauntlet, as it were, to anyone passionate about diabetes and product design. Whether you’re a pharma R&D pro, an independent engineer, a design student or an enterprising patient, we want to hear from you.
    ELIGIBILITY
    This competition is open to all individuals and organizations developing devices or supplies for people with diabetes (medications not included), or enterprising patients with unique prototype concepts. DiabetesMine™ will accept submissions in two categories: under age 18, and age 18 and older.
    CONTEST TIMELINE
    Submissions can be made beginning April 30, 2008, until Monday, May 26st, 2008, at 11:59 pm PST. The winners will be announced on Friday, May 30th, 2008.
    PRIZES
    The winners will receive a combination of rewards intended to help take their ground-breaking diabetes design concept to the next level: prize money, consulting advice, industry event exposure and media coverage.

  • Sponsors Cory and Justin Oringer generously offer $1,000 each in two entry categories: under age 18 and over age 18 (total prize money $2,000).
  • Health and wellness consultants from world-renown design firm IDEO will host a two-hour workshop to help each winner refine their concept.
  • Organizers of the “innovation incubator” Health 2.0 Conference have generously offered one free access ticket to their Fall conference in San Francisco, October 21-23rd, 2008, for the winner of the adult competition.
  • Medgadget and DiabetesMine™ will promote the winners through articles and blogs, and possibly also feature some of the coolest finalists.
  • COMPETITION GUIDELINES

  • All entries must be in the form of a movie or an animation, no more than 2 minutes long (all content in English), which will be submitted by uploading into the DiabetesMine™ channel on YouTube.
  • Each product or design concept must be new, i.e. introduced within the last half-year, or in development phase, possibly undergoing user testing now.
  • One video per product idea only, please.
  • The product or design concept needs to have been created in its entirety by the submitting team, i.e. it must not infringe or violate the rights of any third parties, including, but not limited to the copyrights, patents, trademarks, trade secrets, and right of publicity/privacy.
  • Each video submission needs to contain your brief but complete "Elevator Pitch," covering the following aspects describing your new design:
  • Explanation of the everyday problem(s) your concept is designed to solve – how does it help improve life for people with diabetes?
  • Description of the medical application of the product.
  • Detailed depiction of the product’s look and feel, material, and dimensions. Ideally the video will include a 360-degree shot of the product or design concept.
  • Demonstration of the product in action and its various functions, if possible.
  • Each video segment must display the 2nd Annual DiabetesMine™ Design Challenge screen at the beginning and end for five seconds. (See instructions below on where to download that slide)
  • [for some inspiration, see tips on crafting your Elevator Pitch here. View the sample contest entry videos here. Or browse the various product pitches here.]
    HOW TO SUBMIT YOUR ENTRY
    1. Create your video, and add the DiabetesMine™ Design Challenge screen (downloadable HERE) to appear at the beginning and end for five seconds.
    2. Give your video a short, recognizable title (ideally the product name), to make it easy for readers to vote on favorites.
    3. Go to this site: http://youtube.com/group/DiabetesMineDesignIT, and click on “add a video” to upload.
    4. Post a comment on this blog below providing the following information to help identify your video:

  • Video title
  • Your name and age (category you are entering)
  • Valid email contact info
  • State of residence
  • Your status (medical professional, start-up company, independent designer, student, etc.)
  • 5. Note that by submitting an entry for the 2nd Annual DiabetesMine™ Design Challenge, submitters agree to these additional OFFICIAL CONTEST RULES.
    THE JUDGING CRITERIA
    Winners will be evaluated both popular vote and by a panel of three judges. In a sort of reverse American Idol system, reader voting will be taken into consideration, but the final determination will be made by the judges.
    The judging panel will consist of one MD/Editor from Medgadget, one design expert from IDEO, and Amy Tenderich of DiabetesMine™ providing the patient perspective on user experience/desirability of the product. Entries will be judged on three-pronged criteria:

  • Efficiency – how does it solve a real-life problem for people living with diabetes?
  • Clinical Efficacy – how realistic and applicable is this product from a medical standpoint?
  • Aesthetics – it’s the look and feel, Baby! How good is the pure design?
  • Remember, good design can be applied to anything, even something as "low-tech" as a special container for disposing of used glucose test strips. Let the innovation begin!

    56765gif 2nd Annual DiabetesMine™ Design Challenge

    The official contest website and rules can be found at Diabetes Mine

    glinert Shiny, Happy, MediliciousA research duo from Dartmouth and Dana-Farber Cancer Institute has discovered that cancer medications have names that are associated with “lightness, smallness, and fastness”. Moreover, Gregory Abel, a Dartmouth linguist, goes further to say that there might be a “subtle effect on both the patient taking the medicine and the doctor prescribing it.”

    The study, titled “Chemotherapy as language: Sound symbolism in cancer medication names,” was published online on Feb. 4, 2008, in the journal Social Science and Medicine. Glinert collaborated with Gregory Abel, a co-author on the study who is with the Center for Outcomes and Policy Research at Dana-Farber Cancer Institute and a member of the Dartmouth Class of 1991.
    In their paper, Abel and Glinert explain that the use of language and narrative and its significance in caring for patients has been studied. Their examination adds a linguistic layer to the scholarship, deepening the understanding of how the sounds in a medication’s name might have an underlying symbolism. The team looked at the sound symbolism of 60 frequently used cancer medications. Sound symbolism is the phenomenon where tiny bits of sounds have intrinsic connotations.
    “Medications are a bridge between patients and health care providers, and our findings might point to some symbolic and subtle, yet powerful, associations with the names of those medications,” says Glinert, who is also affiliated with Dartmouth’s program in linguistics and cognitive science. “The fact that sounds that elicit lightness, smallness, and fastness were found in the names of cancer medicines might suggest that it helps patients handle the therapy.”

    Press release: Researcher finds symbolic overtones in the names of cancer medicines

    OTC

    noseplugs Nose Mask for Allergy Sufferers
    Japanese firm Bio International Japan is selling nose filter plugs for people suffering from hay fever, and other environmental allergies. The little pliable filters, being sold in Japan for about $15, are almost invisible save for the little connecting string used to remove the devices. Our take on it? This stuff probably does not work.
    Japanese product page
    (hat tip: DVICE)

    eegdrunk SAM Technology: Testing Attention and Memory in the BrainA new system, based on EEG and proprietary processing software, is being used to assess the ability of the brain to function after alcohol, prescription drugs, or other stimulants.

    [Alan] Gevins, founder of SAM Technology and the San Francisco Brain Research Institute, has developed a system that combines EEG with cognitive testing–computer tests that assess a person’s memory or ability to multitask–to get a more direct measure of the brain’s ability to remember and pay attention. He is now aiming to commercialize the technology, with the eventual goal of using it to more precisely assess cognitive decline and tailor drug prescriptions to minimize cognitive side effects. The technology incorporates both new hardware, to measure electrical activity, and new software, to process those signals.
    Previous research by the group suggests that drinking may be more detrimental to our ability to function than previously thought. The brain effects of alcohol remain two to three hours after the behavioral effects have disappeared, even when blood alcohol level is as low as 0.02 percent, about a quarter of the legal limit for driving in most states. “You might be able to summon short bursts of attention and perform well on a short test, but the brain is still abnormal,” says Aaron Ilan, principal neuroscientist at SAM Technology. “You won’t be able to fully focus on a task like driving for several hours.”

    More at the MIT Tech Review
    SAM Technology company page

  • Artificial Cervical Disc Surgery Cheaper Than Fusion… [WaPo, HealthDay News]
  • Playgroups ‘cut leukaemia risk’ … [BBC]
  • LASIK Patients Tell Their Woes to FDA … [WSJ]
  • Largest study to date finds benefits of ICDs in children… [Children's Hospital Bosto]
  • FDA Approves Relistor for Opioid-Induced Constipation … [FDA]
  • First targeted therapy for melanoma brings hope… [Harvard]
  • Harvard Doc: Academia Needs More Contact With Drugmakers … [WSJ]
  • Research Findings Open New Front in Fight against AIDS Virus… [NIH]
  • Scientists Determine Drug Target for the Most Potent Botulinum Neurotoxin… [Brookhaven National Laboratory]
  • Gene Therapy Improves Vision in Small Clinical Trial… [Howard Hughes Medical Institute]
  • Cranfield University starts breath test research for TB… [Cranfield University]
  • A Great Pox’s Greatest Feat: Staying Alive… [NYT]
  • Chocolate ‘may cut diabetes risk’ … [BBC]
  • 53443weq Absinthe Is Just  BoozeWe have some sad news for all the absinthe aficionados: you are simply alcohol lovers. The whole idea of supposed absinthe exceptionalism is up in flames, so to speak.
    The American Chemical Society explains the results of this latest study:

    A high alcohol content, rather than thujone, the compound widely believed responsible for absinthe’s effects. Although consumed diluted with water, absinthe contained about 70 percent alcohol, giving it a 140-proof wallop. Most gin, vodka, and whiskey are 80 to 100-proof and contain 40-50 percent alcohol or ethanol.
    The study is scheduled for the May 14, 2008 issue of the American Chemical Society’s bi-weekly Journal of Agricultural and Food Chemistry, where the full text of the article can be downloaded now without charge.
    Absinthe took on legendary status in late 19th-Century Paris among bohemian artists and writers. They believed it expanded consciousness with psychedelic effects and called it ‘the Green Fairy’ and ‘the Green Muse.’ The drink’s popularity spread through Europe and to the United States. However, illness and violent episodes among drinkers gave absinthe the reputation as a dangerous drug, and it was banned in Europe and elsewhere.
    In the new study, Dirk W. Lachenmeier and colleagues point out that scientists know very little about the composition of the original absinthe produced in France before that country banned the drink in 1915. Only a single study had analyzed one sample of preban absinthe. The researchers analyzed 13 samples of preban absinthe from sealed bottles-”the first time that such a wide ranging analysis of absinthe from the preban era has been attempted,” they say.
    The analysis included thujone, widely regarded as the ‘active’ ingredient in absinthe. “It is certainly at the root of absinthe’s reputation as being more drug than drink,” according to Lachenmeier. Thujone was blamed for ‘absinthe madness’ and ‘absinthism,’ a collection of symptoms including hallucinations, facial contractions, numbness, and dementia.
    However, the study found relatively small concentrations of thujone, amounts less than previously estimated and not sufficient to explain absinthism. Thujone levels in preban absinthe actually were about the same as those in modern absinthe, produced since 1988, when the European Union (EU) lifted its ban on absinthe production. Laboratory tests found no other compound that could explain absinthe’s effects. “All things considered, nothing besides ethanol was found in the absinthes that was able to explain the syndrome of absinthism,” according to Lachenmeier.
    He says that scientific data cannot explain preban absinthe’s reputation as a psychedelic substance. Recent historical research on absinthism concluded that the condition probably was alcoholism, Lachenmeier indicates.

    Press release: Absinthe uncorked: The ‘Green Fairy’ was boozy — but not psychedelic…
    Image credit: absinthe still life by Agenda893 on Flickr

    43635ros How Roses Handle WaterA team of chemists from Tsinghua University in Beijing, China figured out why tiny water droplets seem to get stuck to petals of red roses. Not unexpectantly, the mechanism, known as the Cassie impregnating wetting state, is a result of nanostructures (“hierarchical micropapillae” and “nanofolds”) on the surface of petals. What does it all have to do with medicine? Well, the usual: possible future medical materials, or other technologies.
    Nature explains:

    The beading of water droplets on natural materials is not a rare thing. But on many flowers and leaves the droplets slide off with the slightest tremble, taking dust and small insects off with them. The effect is known by biologists as ‘self cleaning’ and has been well studied by researchers keen to make better water-repellent materials.
    The water slides off because the surfaces are very rough and spiky at the microscopic scale, and the tips of the spikes are covered in wax. The water molecules therefore come into contact with only a tiny fraction of the surface, and then only to water-repelling wax.
    Lin Feng and her colleagues at Tsinghua University in Beijing found that although rose petals are coated with similar projections, they have wide, gentle-sloping troughs between the spikes, and no wax. The spikes keep the dew drops in a spherical shape, but the water ‘leaks’ into the troughs between spike-covered bumps, giving a bit of ‘stick’ and stopping a small droplet from rolling around (see diagram). Feng and colleagues report this structure in the journal Langmuir.
    Once the team realized what the rose petals were doing to hold water, they were curious whether they could replicate the effect. They put some polyvinyl alcohol onto rose petals and allowed it to set, then peeled off a thin plastic cast of the petal surface. This film, the researchers found, had the same properties as the rose petal: the film could hold droplets of between 3-5 microlitres even when held upside down…
    For a rose, this stickiness might come in handy as reflective water drops that glisten in the Sun might attract pollinating insects. In the lab, such materials might be useful for ‘lab on a chip’ devices that need to hold and shunt around tiny quantities of liquid without leaking or being contaminated by nearby materials.

    Read: Raindrops on roses…
    Abstract: Petal Effect: A Superhydrophobic State with High Adhesive Force Langmuir, 24 (8), 4114 -4119, 2008.
    Image credit: . . . captured in a rose by fmarq on Flickr

    petmonkey Salvia Divinorums Mysteries Being StudiedSalvia divinorum, an unusual psychoactive sage described by a Brookhaven National Lab scientist as “probably one of the most potent hallucinogens known,” is currently on brisk sale throughout lower Manhattan, as well as most of the rest of the country where it is currently legal. The plant has gained some popularity over the years, and scientists are trying to learn more about its interaction with the brain.

    Hooker [Jacob Hooker, chemist at Brookhaven and lead author of the study --ed.] and fellow researchers used positron emission tomography, or PET scanning, to watch the distribution of salvinorin A in the brains of anesthetized primates. In this technique, the scientists administer a radioactively labeled form of salvinorin A (at concentrations far below pharmacologically active doses) and use the PET scanner to track its site-specific concentrations in various brain regions.
    Within 40 seconds of administration, the researchers found a peak concentration of salvinorin A in the brain – nearly 10 times faster than the rate at which cocaine enters the brain. About 16 minutes later, the drug was essentially gone. This pattern parallels the effects described by human users, who experience an almost immediate high that starts fading away within 5 to 10 minutes.
    High concentrations of the drug were localized to the cerebellum and visual cortex, which are parts of the brain responsible for motor function and vision, respectively. Based on their results and published data from human use, the scientists estimate that just 10 micrograms of salvia in the brain is needed to cause psychoactive effects in humans.
    Salvia doesn’t cause the typical euphoric state associated with other hallucinogens like LSD, Hooker said. The drug targets a receptor that is known to modulate pain and could be important for therapies as far reaching as mood disorders.
    “Most people don’t find this class of drugs very pleasurable,” Hooker said. “So perhaps the main draw or reason for its appeal relates to the rapid onset and short duration of its effects, which are incredibly unique. The kinetics are often as important as the abused drug itself.”
    The Brookhaven team plans to conduct further studies related to salvia’s abuse potential. The scientists also hope to develop radioactive tracers that can better probe the brain receptors to which salvia binds. Such studies could possibly lead to therapies for chronic pain and mood disorders.

    Press release: Brookhaven Scientists Explore Brain’s Reaction to Potent Hallucinogen
    PET images (color) of [11C]-salvinorin A in the baboon brain overlaid on MRI template (black and white) summed from 3-7 minutes post-injection. High concentrations (red) were observed in the cerebellum and activity was seen throughout cortical and subcortical regions. The maximum concentration of [11C]-salvinorin A in the brain occurs in 40 seconds and clears with a half-life of only 8 minutes, matching the pharmacological duration of action.

    LIMITORR LimiTorr Volume Limiting Cerebral Spinal Fluid Drainage SystemIntegra LifeSciences is introducing its new CSF drainage system that features a shutoff valve that activates when a preset amount of fluid enters the bag, increasing the safety of the patient as well as reducing the workload on nurses that otherwise have to manually monitor the level.

    The LimiTorr(TM) Volume Limiting CSF Drainage System can be used for both lumbar and ventricular drainage. It includes a volume-limiting valve mechanism, which halts drainage when the pre-determined volume of 20 mL or 30 mL is met. This safety mechanism helps prevent CSF overdrainage, which can lead to subdural hematomas, brainstem herniation or death.
    CSF drainage is an important component of managing the intracranial pressure of a neuro-compromised patient or a patient undergoing abdominal aortic aneurysm surgery. “This product increases patient safety, and reduces the stress of those caring for patients undergoing lumbar subarachnoid or cranial CSF drainage; it’s also safer than other devices I have used,” said Dr. McDermott.
    Dr. McDermott had clinicians in mind, as well as patient safety, when he envisioned the LimiTorr(TM) system. “For patients, this device reduces the likelihood of CSF overdrainage. For nurses, the device helps reduce the anxiety associated with having to constantly monitor the drainage volume to prevent CSF overdrainage, and allows them to devote more time to other patient care issues.”

    Press release: Integra LifeSciences Announces Launch of the LimiTorr Volume Limiting CSF Drainage System